Summary
IgG4 comprises a significant proportion of the total anti-Fab antibody (aFABA) response in many but not all patients with rheumatoid arthritis (RA). Analyses of the dynamics of IgG aFABA subclass expression in 11 RA patients for periods of up to 11 months demonstrated that IgG4 aFABA was restricted to 6 of the 11 RA patients' sera initially studied and comprised approximately 25% (or more) of the total IgG aFABA response. Quantities of IgG4 aFABA in subsequent, serially obtained serum samples from these patients remained stable throughout the study period, whereas the remaining RA patients whose initial sera possessed small quantities of serum IgG4 aFABA failed to generate any augmented IgG4 aFABA response during the study. Elevated expression of IgG4 aFABA did not appear to be a consequence of a generalized polyclonal gammopathy or a generalized increase in autoantibody expression, though patients with higher total IgG4 serum levels expressed significantly greater quantities of IgG4 aFABA. These results indicate that the differential expression of IgG4 aFABA among RA patients reflects constitutive production within a subset of RA patients in whom IgG4 appears to comprise a significant proportion of the total IgG aFABA response.
Similar content being viewed by others
References
Nasu H, Chia D, Knutson DW, Barnett EV (1980) Naturally occurring human antibodies to the F(ab′)2 portion of IgG. Clin Immunol 42:378–386
Silvestris F, Bankhurst AD, Searles RP, Williams RC Jr (1984) Studies of anti-F(ab′)2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosus. Arthritis Rheum 27:1387–1396
Morgan AC, Rossen RD, McCormick KJ, Stehlin JS Jr, Giovanella BC (1982) “Hidden” cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells are contained in soluble immune complexes from normal human sera. Cancer Res 42:881–887
Davey MP, Korngold L (1982) Association of anti-F(ab′)2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays. Int Arch Allergy Appl Immunol 67:278–283
Ling NR, Drysdale P (1981) Antibodies in human sera to F(ab′)2 fragments of monoclonal and polyclonal IgG. Int Arch Allergy Appl Immunol 66:459–463
Silvestris F, Williams RC Jr, Serales RP (1986) Human anti-F(ab′)2 antibodies and pepsin agglutinators react with Fv determinants. Scand J Immunol 23:499–508
Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125 c:373–389
Birdsall HH, Rossen RD (1984) Regulation of antibody release by naturally occurring anti-immunoglobulins in culture of pokeweed mitogen-stimulated human peripheral blood lymphocytes. J Immunol 133:1257–1264
Persselin JE, Louie JS, Stevens RS (1984) Clonally restricted anti-IgG antibodies in rheumatoid arthritis. Arthritis Rheum 27:1378–1386
Persselin JE, Stevens RH (1985) Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G sub-classes in rheumatoid arthritis. J Clin Invest 76:723–730
Aalberse RC, Gaag R van der, Leeuwen J van (1983) Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130:722–726
Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–176
Persselin JE, Keld B, Friedl L, Stevens RH (1985) Sub-classes of human IgG anti-Fab antibodies: parameters for optimum detection. Int Arch Allergy Appl Immunol 78:368–374
Sluyterman LA, Wijdenes J (1978) Chromatofocusing: isoelectric focusing on ion exchange columns. I. General principles. J Chromatogr 150:17–30
Voller A, Bidwell DE, Barlett A (1976) Enzyme-immunoassays in diagnostic medicine. Theory and practice. Bull WHO 53:55–65
Jefferis R, Reimer CB, Skvaril F et al. (1985) Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett 10:223–252
Gilbert B, Dighiero G, Avrameas S (1982) Naturally occurring antibodies against nine common antigens in normal humans. I. Detection, isolation and characterization. J Immunol 128:2779–2787
Prabhakar BS, Saegusa J, Onodera T, Notkina AL (1984) Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 133:2815–2817
Fong S, Carson DA, Vaughan JH (1985) Rheumatoid factor. In: Gupta S, Talal N (eds) Immunology of rheumatic diseases. Plenum, New York London, pp 167–196
Leibling MR, Wong C, Radosevich J (1985) Spontaneous in vitro production of anti-DNA and anti-RNA by systemic lupus erythematosus and normal peripheral blood mononuclear cells. Arthritis Rheum 28:431–440
Talal N, Pillarisetty RJ, DeHoratius RJ, Messner RP (1976) Immunologic regulation of spontaneous antibodies to DNA and RNA. I. Significance of IgM and IgG antibodies in SLE patients and asymptomatic relatives. Clin Exp Immunol 25:377–382
Sontheimer RD, Gilliam JN (1978) DNA antibody class, subclass, and complement fixation in SLE with and without nephritis. Clin Immunol Immunopathol 10:459–467
Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685
Mikkelson WM, Dodge H (1969) A 4-year follow-up of suspected rheumatoid arthritis. Arthritis Rheum 12:87–91
Williams RC, Kunkel HG (1962) Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis. J Clin Invest 41:666–675
Almeida JD, Griffith AH (1980) Viral infections and rheumatic factor. Lancet II:1361–1362
Gerardo SH, Persselin JE, Keld B, Stevens RH (1988) Anti-Fab antibodies in rheumatoid arthritis recognize a structure(s) widely distributed on human Fab molecules. Scand J Immunol (in press)
Djurup R, Osterballe O (1984) IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Allergy 39:433–441
Iskander R, Das PK, Aalberse RC (1981) IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol 66:200–207
Muller-Eberhard HJ (1968) Chemistry and reaction mechanisms of complement. Adv Immunol 8:1–80
Lawrence DA, Weigle WO, Spiegelburg HL (1975) Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophil. J Clin Invest 55:368–376
Lewis EJ, Busch GJ, Schur PH (1970) Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest 49:1103–1113
Doi T, Mayumi M, Kanastu K, Suehiro F, Hamashima Y (1984) Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 58:57–62
Zee JS van der, Swieten P van, Aalberse RC (1986) Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 64:415–422
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Persselin, J.E., Stevens, R.H. Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed. Rheumatol Int 8, 205–211 (1988). https://doi.org/10.1007/BF00269196
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00269196